Genmab — December 2017
-
New:
A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma - https://clinicaltrials.gov/show/NCT03384654 -
Så har Myelomatoseforeningen lagt videoer fra deres seminar i november ud på nettet: https://www.myelomatose.dk/blog/
-
-
God morgen

-
God morgen.

-
Til en gråvejrsdag. https://play.borsen.dk/klip/5a43b89745628ff8172175fd
-
Men en ok opsamling af Florian.
-
Ja altid fornuftigt at høre Florian omkring Genmab casen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind